Is Oncogene Addiction Angiogenesis-dependent?

  1. J. FOLKMAN and
  2. S. RYEOM
  1. The Vascular Biology Program, Department of Surgery, Children's Hospital and Harvard Medical School, Boston, Massachusetts 02115.

Abstract

Does an activated oncogene that initiates tumor growth need to remain activated to maintain the cancer phenotype? This questionhas been answered affirmatively by experiments in which doxycycline-regulated oncogene activation induces growth oflarge tumors that regress completely upon oncogene inactivation—a phenomenon called oncogene addiction. We assemblehere the evidence that oncogene addiction is angiogenesis-dependent. Although activated oncogenes increase tumor cell proliferationand decrease their apoptosis, these activities are not sufficient to expand tumor mass beyond a microscopic size.Oncogenes must also induce tumor angiogenesis for expansion of tumor mass. We propose experiments to validate the "endothelialcentric" hypothesis of oncogene addiction.

Footnotes

| Table of Contents